Please login to the form below

Not currently logged in
Email:
Password:

Srdjan Stankovic joins Acadia Pharmaceuticals

He moves to the San Diego biopharma from Alkermes

San Diego biopharmaceutical company Acadia Pharmaceuticals has appointed Srdjan (Serge) Stankovic as executive vice president, head of research and development.

He joins the firm from Alkermes, where he most recently served as senior vice president of clinical development and medical affairs from 2013 to 2015.

Prior to this he worked at Teva as senior vice president and head of global clinical development following that company's acquisition of Cephalon, where he was senior vice president, worldwide clinical research. 

Stankovic has also held executive positions in research and development at Forest Laboratories, Neurogen, Johnson and Johnson and UCB.

Steve Davis, Acadia's president and chief executive officer, said: “Serge has a track record of transforming promising research into important medicines that address unmet needs of patients.

"We look forward to his contributions as we advance Nuplazid through NDA review for Parkinson's disease psychosis, prepare for the planned commercialisation of Nuplazid in the US  and continue our efforts to explore the full potential of Nuplazid to treat patients suffering from additional CNS disorders.” 

Nuplazid (pimavanserin), Acadia's lead candidate, has been submitted to the US FDA for a licence to treat Parkinson's disease psychosis, a condition that currently has no approved treatment.

Stankovic said: “There is a strong need for continued innovation in the treatment of CNS disorders such as Parkinson's disease, Alzheimer's disease, and schizophrenia. Acadia is at the forefront in developing groundbreaking medicines to treat debilitating symptoms associated with these diseases.

"I look forward to leading the team in advancing the promising development programmes with Nuplazid."

11th January 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

It’s all about patient outcomes… right?
Lessons from history: a design thinking perspective...
Emma Walmsley 2
30 Women Leaders in UK Healthcare (part 3)
Continuing our special feature on Women Leaders in UK Healthcare...
Louise Houson
30 Women Leaders in UK Healthcare
The enormous challenges facing UK healthcare mean it needs great leaders. PME’s Group Editor Andrew McConaghie introduces 30 outstanding innovators and trailblazers helping to shape the future...

Infographics